Investigation with PC-3 metastatic prostate cancer cells revealed that exogenous irisin reduced cell viability, while tumor growth and progression were reduced in vivo, suggesting that apoptotic pathways were enhanced by irisin (91). This evidence concerns the gene FNDC5 and neoplasm.